# Viracor-IBT Laboratories – FDA Inspection, Mar 26, 2025

Source: https://www.keypedia.com/records/fda_inspections/viracor-ibt-laboratories/497f3d5f-7b7d-4c35-8de5-d81631b3ab5b
Source feed: FDA_Inspections

> FDA inspection 1265586 of Viracor-IBT Laboratories, March 26, 2025. Classification: No Action Indicated (NAI). 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1265586
- Company Name: Viracor-IBT Laboratories
- Inspection Date: 2025-03-26
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 989116 - 2016-08-23
- FDA Inspection 681077 - 2010-09-27

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/celeta-s-coves/d0f63577-a6e4-4872-b06c-a024188a04ba)

Company: https://www.keypedia.com/companies/viracor-ibt-laboratories/8f51d515-41ae-4d48-b103-2b36947ad13e

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d